请输入您要查询的百科知识：

　

词条 Macrogen
释义

  1. Business model

  2. Corporate governance

  3. Strategic and tactical relationships

  4. Macrogen Corp

  5. References

  6. Notes

{{Infobox company
|name = Macrogen, Inc.
|type = Public
|traded_as = {{Korea Exchange|038290}}
|founded = {{start date|1997}}
|founder = Jeong-sun Seo
|area_served = global
|key_people = Hyon-yong Chong (CEO, 2015)
|products = {{unbulleted list|DNA sequencing|Bioinformatic analysis}}
|divisions = {{unbulleted list|Macrogen Korea|Macrogen Japan|Macrogen Europe|Macrogen USA}}
|location_city = Seoul
|location_country = South Korea
|homepage = {{url|www.macrogen.com}}

}}Macrogen, Inc. is a South Korea public biotechnology company.[1] The company's headquarters are located in Seoul.[2] The company was founded in 1997 by Jeong-sun Seo,[3] a professor at Seoul National University.[4] It was venture capital-backed until its initial public offering (IPO) and subsequent listing on the KOSDAQ market in 2000, making it the first Korean biotechnology firm to raise funds through an IPO.[1][4] The company announced plans in 2010 to map the "Korean genome" based on the notion that United States-backed genome mapping efforts up to that time were representative of the "Caucasian genome" rather than the "Human genome" as claimed.[5] By 2015, the company was described by one news outlet as "a global leader in personalized genomic medicine".[6]

Business model

Macrogen's business model focuses on providing research services to other firms engaged in biotechnology research and development.[4] {{As of|2005}}, 50% of the firm's revenue was derived from DNA sequencing services.[4] Prior to its 2000 IPO, the company aimed to be the low-cost leader in providing research services; after the IPO, Macrogen turned to DNA sequencing technology development as a way to distinguish itself from competitors.[4] {{As of|2015}}, the company had four main divisions based on geography: Korea, USA, Europe and Japan.[7]

Consistent with the post-IPO competitive technology strategy was Macrogen's being among the first customers to purchase a HiSeq X Ten System from Illumina in January 2014,[8] purported to be the first sequencing system to enable cracking the $1,000 genome boundary.[9]

In 2015, the company underwent a corporate identity revision, which included a revised corporate logo and a revised corporate slogan: "Humanizing Genomics."[6]

Corporate governance

As of 2014, HyungTae Kim held the role of chief executive officer (CEO) at Macrogen.[2] By early 2015, however, the CEO role had been filled by Hyon-yong Chong.[6]

With respect to the company's Board, founder Jeong-sun Seo remained Chairman as of 2015.[6]

According to KOSDAQ statistics, over 90% of the company's outstanding stock is held by individual investors.[10]

Strategic and tactical relationships

In late 2014, Macrogen licensed Clarity LIMS from GenoLogics, a system "built specifically for the needs of clinical or research genomics and mass spec laboratories".[8] Initial integration with service offerings was to be through the USA-based Macrogen Clinical Laboratory.[8]

In 2014 and 2015, Macrogen won competitive bidding rounds to provide genome analysis services to the University College London.[11]

Macrogen Corp

References

1. ^1 {{Cite journal|url = https://books.google.com/books?id=mA1WAAAAYAAJ&focus=searchwithinvolume&q=macrogen|title = (unknown)|last = |first = |date = 2002|journal = Korea Now|doi = |pmid = |access-date = 2015-07-14|volume = 31|via = Google Books (snippet view)|isbn=978-2916914534}}
2. ^1 {{Cite news|url = http://www.highbeam.com/doc/1G1-394055079.html|archive-url = https://web.archive.org/web/20150924155033/http://www.highbeam.com/doc/1G1-394055079.html|dead-url = yes|archive-date = September 24, 2015|title = Macrogen Introduces Latest Service Portfolio and Presents Research Outcome at 2014 ASHG Annual Meeting|last = Staff|date = November 3, 2014|work = Biotech Business Week|access-date = 2015-07-15|via = HighBeam Research}}
3. ^"Jeong-sun Seo" in one news citation.
4. ^1 2 3 4 {{Cite book|title = Betting on Biotech: Innovation and the Limits of Asia's Developmental State|url = https://books.google.com/books?id=vLpsxuLlVJIC|publisher = Cornell University Press|date = September 15, 2011|isbn = 0801463386|first = Joseph|last = Wong|via = Google Books (preview)|pages = 97–8}}
5. ^{{Cite book|title = Frameworks of Choice: Predictive & Genetic Testing in Asia|url = https://books.google.com/books?id=Io9YSm91zGQC|publisher = Amsterdam University Press|date = 2010|isbn = 9789089641656|first = Margaret|last = Sleeboom-Faulkner|page = 28|via = Google Books (full view)}}
6. ^1 2 3 {{Cite news|url = http://www.highbeam.com/doc/1G1-415152531.html|archive-url = https://web.archive.org/web/20150924155122/http://www.highbeam.com/doc/1G1-415152531.html|dead-url = yes|archive-date = September 24, 2015|title = Macrogen Renews CI after 19 Years, Making a Great Leap Forward to Be a Global Leader of Personalized Genomic Medicine|last = Staff|date = April 15, 2015|work = Biotech Week|access-date = 2015-07-15|via = HighBeam Research}}
7. ^{{Cite web|title = Macrogen|url = http://www.macrogen.com/eng/|website = www.macrogen.com|accessdate = 2015-07-15|at = See footer content}}{{self published-inline|date=July 2015|certain=y}}
8. ^1 2 {{Cite news|url=http://www.highbeam.com/doc/1G1-394289098.html|archive-url=https://web.archive.org/web/20150924155035/http://www.highbeam.com/doc/1G1-394289098.html|dead-url=yes|archive-date=September 24, 2015|title=Macrogen Selects GenoLogics' Clarity LIMS to Strengthen X-Genome and Clinical Sequencing Services|last=Staff|date=November 4, 2014|work=Information Technology Newsweekly|access-date=2015-07-15|via=HighBeam Research}}
9. ^{{Cite press release|title = Illumina Introduces the HiSeq X™ Ten Sequencing System|url = http://investor.illumina.com/phoenix.zhtml?c=121127&p=irol-newsArticle&ID=1890696|date = January 14, 2014|publisher = Illumina|access-date = 2015-07-15}}
10. ^{{Cite web|url = http://eng.krx.co.kr/por_eng/m2/m2_1/m2_1_5/JHPENG02001_05.jsp|title = Trading Performance by Investor|accessdate = 2015-07-15|website = KRX Korea Exchange|publisher = Korea Exchange|at = Sort table by percent|quote = 91.84 (in percent field for row with investor value "Individual")}}
11. ^{{Cite news|url = |title = Products & Services|last = Staff|date = June 15, 2015|work = Genetic Engineering & Biotechnology News|access-date = |via = |page = 8|department = News|volume = 35|issue = 12}}

Notes

{{Reflist|group = note}}

8 : Biotechnology companies established in 1997|Companies listed on KOSDAQ|Companies based in Seoul|Genomics companies|1997 establishments in South Korea|Research support companies|Medical technology companies of South Korea|South Korean brands
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/9/22 17:19:02